Attention Shareholders: Important Updates on Allarity Therapeutics, Inc. Investment Losses and Upcoming Deadlines
Class Action Lawsuit Filed Against Allarity Therapeutics, Inc. Background On October 25, 2024, Pomerantz LLP announced that a class action lawsuit has been filed against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR) and certain officers. The class action was filed in the United States District Court for the Southern District of New York,…